Clinical Trial Update: Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated pregabalin for the prevention and reduction of oxaliplatin-induced painful peripheral neuropathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain
• Oxaliplatin-induced Peripheral Neuropathy
• Polyneuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Pain, Neuropathic Pain | Phase 3 | Status: COMPLETED